PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Apr-2026 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Apr-2026 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Apr-2026 Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Apr-2026 SV Health Investors Acquires EpiVax Businesswire
02-Apr-2026 Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights Businesswire
02-Apr-2026 Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026 ACCESS Newswire
02-Apr-2026 Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines Businesswire
02-Apr-2026 Dialogue with HighTide Therapeutics' CMO Dr. Filip Surmont: Moving Beyond the 'Blockbuster' Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach HighTide Therapeutics Inc.
02-Apr-2026 OMRON Healthcare and UCSF launch AFib trial OMRON Healthcare
02-Apr-2026 CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline Businesswire
02-Apr-2026 PharmaEssentia Signs Investment Agreement for New Manufacturing Facility in Puerto Rico Businesswire
02-Apr-2026 Modus Create Achieves Amazon Web Services (AWS) Migration Acceleration Program (MAP) Competency Businesswire
02-Apr-2026 Glycomine Completes Enrollment in Global Phase 2b POLAR Study of GLM101 for the Treatment of PMM2-CDG Businesswire
02-Apr-2026 Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable Businesswire
02-Apr-2026 Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing Businesswire
02-Apr-2026 Everus Acquires SE&M, Leading Contractor in Southeast Region Businesswire
02-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Apr-2026 Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board Businesswire
02-Apr-2026 Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director Businesswire
02-Apr-2026 Wugen Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of Soficabtagene Geleucel Businesswire